ORESTES MOLDES: Open Payments
NPI 1215489596 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 29 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $1,406 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $594 |
| Phathom Pharmaceuticals, Inc. | 3 | $213 |
| PFIZER INC. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: SKYRIZI, VOQUEZNA, RINVOQ, CREON, XELJANZ, REZDIFFRA, IQIRVO, ZENPEP.
Industry payments across TX — which companies pay providers there.
